Sigilon Therapeutics, Inc. EBITDA 2021-2023 | SGTX
Sigilon Therapeutics, Inc. ebitda from 2021 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Sigilon Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-42 |
| 2021 | $-75 |
| 2020 | $-52 |
| 2019 | $-43 |
| Sigilon Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-06-30 | $-7 |
| 2023-03-31 | $-7 |
| 2022-12-31 | $-7 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-14 |
| 2022-03-31 | $-13 |
| 2021-12-31 | $-17 |
| 2021-09-30 | $-19 |
| 2021-06-30 | $-20 |
| 2021-03-31 | $-18 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-12 |
| 2020-06-30 | $-13 |
| 2020-03-31 | $-12 |
